The early growth response protein 1-miR-30a-5p-neurogenic differentiation factor 1 axis as a novel biomarker for schizophrenia diagnosis and treatment monitoring

To date, diagnosis of schizophrenia is still based on clinical interviews and careful observations, which is subjective and variable, and can lead to misdiagnosis and/or delay in diagnosis. As early intervention in schizophrenia is important in improving outcomes, objective tests that can be used fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, S, Zhang, F, Shugart, Y Y, Yang, L, Li, X, Liu, Z, Sun, N, Yang, C, Guo, X, Shi, J, Wang, L, Cheng, L, Zhang, K, Yang, T, Xu, Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545732/
https://www.ncbi.nlm.nih.gov/pubmed/28072411
http://dx.doi.org/10.1038/tp.2016.268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545732/
https://www.ncbi.nlm.nih.gov/pubmed/28072411
http://dx.doi.org/10.1038/tp.2016.268

Ejemplares similares